21501 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
Sub-classes:THERAPEUTIC NANOCONJUGATES AND USES THEREOF
#2COMPOSITIONS AND METHODS RELATING TO CELLS WITH ADHERED PARTICLES
#3Therapeutic use of mitochondria and combined mitochondrial agents
#4THERAPEUTIC USE OF MITOCHONDRIA AND COMBINED MITOCHONDRIAL AGENTS
#5HYDROGEL
#6Therapeutic nanoconjugates and uses thereof
#7MRI-DETECTABLE MULTILAYER MICROCAPSULES FOR ULTRASOUND-TRIGGERED DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS
#8THERAPEUTIC USE OF MITOCHONDRIA AND COMBINED MITOCHONDRIAL AGENTS
#9Self assembling molecules for targeted drug delivery
#10Magnetic microstructures for magnetic resonance imaging
#11Peptides that target inflamed or distressed cardiac tissue and uses related thereto
#12HYDROPHILIC PARTICLES, METHOD FOR PRODUCING THE SAME, AND CONTRAST AGENT UTILIZING SAME
#13SELF ASSEMBLING MOLECULES FOR TARGETED DRUG DELIVERY
#14Therapeutic use of mitochondria and combined mitochondrial agent
#15Nanostars and nanoconstructs for detection, imaging, and therapy
#16Methods and apparatuses for the localization and treatment of disease such as cancer
#17COMPOUNDS HAVING MAGNETIC FUNCTIONALITY, IMPLANTS OR GELS DERIVED FROM SAME, AND USE OF BOTH IN ORDER TO DETERMINE THE ENZYME ACTIVITY OF AN ENZYME
#18Modulation of a response signal to distinguish between analyte and background signals
#19Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
#20Scanning suspension comprising a particle with a diameter of at least 1 micrometer
#21Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
#22MATRIX METALLOPROTEASE TARGETING NUCLEIC ACIDS
#23Nanoparticulate manganese MRI contrast agents
#24Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
#25MULTIMODAL VISIBLE POLYMER EMBOLIZATION MATERIAL
#26MATRIX METALLOPROTEASE TARGETING NUCLEIC ACIDS
#27DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING PLATELET ACTIVATION
#28Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
#29TARGETING AGENTS FOR MOLECULAR IMAGING
#30Particle immobilized coatings and uses thereof
#31Diagnosis and treatment of diseases involving platelet activation
#32Responsive MRI contrast agents
#33SONO-ACTIVE LIPOSOMES AND LIPID PARTICLES AND USE THEREOF AS CONTRAST AGENTS AND ACTIVE-AGENT DELIVERY SYSTEMS
#34Coated stent assembly and coating materials
#35Scanning suspension comprising a particle with a diameter of at least 1 micrometer
#36Contrast agents
#37Contrast agents
#38Paramagnetic polymerized protein microspheres and methods of preparation thereof
#39Nanoparticle-mediated methods for antimicrobial susceptibility testing of bacteria